BM BIO7
Active substance: SODIUM SULFATE, TRIBASIC CALCIUM PHOSPHATE, POTASSIUM PHOSPHATE, DIBASIC, FERROSOFERRIC PHOSPHATE, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
GLOBULE · SODIUM SULFATE 3 [hp_X]/g, TRIBASIC CALCIUM PHOSPHATE 3 [hp_X]/g, POTASSIUM PHOSPHATE, DIBASIC 3 [hp_X]/g, FERROSOFERRIC PHOSPHATE 3 [hp_X]/g, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 3 [hp_X]/g
United StatesActive
Marketing holder: BM Private Limited
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- SODIUM SULFATE · 3 [hp_X]/g
- TRIBASIC CALCIUM PHOSPHATE · 3 [hp_X]/g
- POTASSIUM PHOSPHATE, DIBASIC · 3 [hp_X]/g
- FERROSOFERRIC PHOSPHATE · 3 [hp_X]/g
- SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE · 3 [hp_X]/g
Registration
- Registration number
- 85816-3007
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 85816-3007 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 85816-3007 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 85816-3007 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 85816-3007 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 85816-3007 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 85816-3007 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 85816-3007 · Verified 2026-10-09 · open in source